Document Detail


Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey.
MedLine Citation:
PMID:  22686959     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objective: Knowledge of patients' treatment needs is an important requirement for comprehensive long-term patient care. The objective of this investigation was to assess the requirements of patients with Parkinson's disease (PD) regarding pharmacotherapy. Methods: A total of 17,500 members of the German Parkinson Association were given the opportunity to anonymously answer a questionnaire about their health-related quality of life, PD pharmacotherapy and their improvement suggestions for new PD medication. Results: Answers from 6351 patients were available for analysis. The majority (87.2%) of patients were older than 60 years; 88.9% had been diagnosed with PD for longer than 3 years and 84.4% selected one of the three most severe categories (categories 1-3 on a 6-point scale) when rating the impact of PD on their quality of life. Symptoms that were regarded as very important for improvement with pharmacotherapy included motor fluctuations (66.3%), early morning akinesia (55.4%) and sleep disturbances (43.5%). Properties of a new PD medication that were rated as very important included continuous drug delivery over 24 hours (66.6%) and 24-hour symptom control (55.8%). The majority of patients used physicians (84.2%) and/or self-help groups (69.4%) to obtain information about PD. Topics of particular interest included comorbid diseases (78.3%), mobility and exercise (77.3%) and research (53%). Conclusion: PD has a major impact on patients' quality of life. From the patient's perspective, PD pharmacotherapy needs to address a range of symptoms including not only motor symptoms, but also nonmotor symptoms such as sleep disturbances. In selecting the most appropriate treatment regimen, patient preference is an important consideration.
Authors:
Ullrich Wüllner; Gerd Fuchs; Nicole Reketat; Olaf Randerath; Jan Kassubek
Related Documents :
21558859 - Descriptive analysis of oxygen use in australian emergency departments.
19827989 - Therapy of community-acquired acute bacterial meningitis: the clock is running.
2845779 - Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with...
956879 - Restricted fluid intake. rational management of the neurosurgical patient.
21817969 - The impact of discharging minimally injured trauma patient: does age play a role in tra...
12458049 - Increased expression of the th1-inducing cytokines interleukin-12 and interleukin-18 in...
21558859 - Descriptive analysis of oxygen use in australian emergency departments.
20373909 - Domiciliary experience of the target inhalation mode (tim) breathing maneuver in patien...
16908219 - Treatment of patients with coexisting epileptic and nonepileptic seizures.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-11
Journal Detail:
Title:  Current medical research and opinion     Volume:  -     ISSN:  1473-4877     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myopathy during statin-therapy in the daily practice of an outpatient cardiology clinic: prevalence,...
Next Document:  Behavioral Characteristics of Internet Gamblers Who Trigger Corporate Responsible Gambling Intervent...